Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1086/506361 http://scihub22266oqcxt.onion/10.1086/506361 16941345!?!16941345 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=16941345&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Infect+Dis 2006 ; 194 (6): 790-4 Nephropedia Template TP {{tp|p=16941345|t=2006. Parvovirus B19 empty capsids as antigen carriers for presentation of antigenic determinants of dengue 2 virus |pdf=|usr=}}{{16941345}} gab.com Text Parvovirus B19 empty capsids as antigen carriers for presentation of antigenic determinants of dengue 2 virus JO: J Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=16941345 #FOAvip For the production of dengue-vaccine candidates, empty capsids, or virus-like particles (VLPs), of parvovirus B19 that carry dengue 2-specific epitopes were employed as antigen carriers. Two epitopes (comprising amino acids 352-368 and 386-397) of domain BIII of the envelope glycoprotein were chosen to produce recombinant B19 VLPs for immunization of BALB/c mice. Serum samples from immunized mice revealed that recombinant B19 VLPs elicited strong humoral immune responses. In summary, this B19 VLP-vaccine platform produced high (> or =2.0 x 10(5)) anti-dengue 2 titers and robust (< or =1 120) 50%-plaque-reduction neutralization test (PRNT(50)) titers, which effectively neutralized live dengue 2 virus in PRNT(50) assays. Twit Text FOAVip Parvovirus B19 empty capsids as antigen carriers for presentation of antigenic determinants of dengue 2 virus ????J Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=16941345 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=16941345 #FOAvip English Wikipedia <ref>{{Cite pmid|16941345}}</ref> Parvovirus B19 empty capsids as antigen carriers for presentation of antigenic determinants of dengue 2 virus #MMPMID16941345 Amexis G; Young NS J Infect Dis 2006[Sep]; 194 (6): 790-4 PMID16941345show ga For the production of dengue-vaccine candidates, empty capsids, or virus-like particles (VLPs), of parvovirus B19 that carry dengue 2-specific epitopes were employed as antigen carriers. Two epitopes (comprising amino acids 352-368 and 386-397) of domain BIII of the envelope glycoprotein were chosen to produce recombinant B19 VLPs for immunization of BALB/c mice. Serum samples from immunized mice revealed that recombinant B19 VLPs elicited strong humoral immune responses. In summary, this B19 VLP-vaccine platform produced high (> or =2.0 x 10(5)) anti-dengue 2 titers and robust (< or =1 120) 50%-plaque-reduction neutralization test (PRNT(50)) titers, which effectively neutralized live dengue 2 virus in PRNT(50) assays. |Animals[MESH] |Antibodies, Viral/blood/metabolism[MESH] |Antigen Presentation/*physiology[MESH] |Capsid Proteins/genetics/*immunology[MESH] |Cell Line[MESH] |Dengue Virus/genetics/*immunology[MESH] |Epitopes/genetics/metabolism[MESH] |Gene Order[MESH] |Mice[MESH] |Mice, Inbred BALB C[MESH] |Neutralization Tests[MESH] |Parvovirus B19, Human/genetics/*immunology[MESH] |Recombinant Proteins/*immunology[MESH]Parvovirus B19 empty capsids as antigen carriers for presentation of a(epmc).pdf DeepDyve Pubget Overpricing